Enovis Corp - Asset Resilience Ratio
Enovis Corp (ENOV) has an Asset Resilience Ratio of 4.51% as of September 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check ENOV PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2018)
This chart shows how Enovis Corp's Asset Resilience Ratio has changed over time. See Enovis Corp balance sheet quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Enovis Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ENOV company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $200.27 Million | 4.51% |
| Total Liquid Assets | $200.27 Million | 4.51% |
Asset Resilience Insights
- Limited Liquidity: Enovis Corp maintains only 4.51% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Enovis Corp Industry Peers by Asset Resilience Ratio
Compare Enovis Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
Shenzhen Lifotronic Technology Co
SHG:688389 |
Medical Devices | 2.53% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
Annual Asset Resilience Ratio for Enovis Corp (2017–2018)
The table below shows the annual Asset Resilience Ratio data for Enovis Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-12-31 | 0.00% | $0.00 | $6.60 Billion | -- |
| 2017-12-31 | 2.23% | $149.61 Million | $6.72 Billion | -- |
About Enovis Corp
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compres… Read more